Cargando…
Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A
The anthracycline antibiotic doxorubicin is commonly used antineoplastic drug in breast cancer treatment. Like most chemotherapy, doxorubicin does not selectively target tumorigenic cells with high proliferation rate and often causes serve side effects. In the present study, we demonstrated the cell...
Autores principales: | Hou, Jin-Gang, Jeon, Byeong-Min, Yun, Yee-Jin, Cui, Chang-Hao, Kim, Sun-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429443/ https://www.ncbi.nlm.nih.gov/pubmed/30871042 http://dx.doi.org/10.3390/ijms20051244 |
Ejemplares similares
-
Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh(2) on MDA-MB-231 and MCF-7 Human Breast Cancer Cells
por: Ren, Guixing, et al.
Publicado: (2018) -
Differential Expression of HSP90β in MDA-MB-231 and MCF-7 Cell Lines after Treatment with Doxorubicin
por: Jokar, Fereshte, et al.
Publicado: (2019) -
Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells
por: Pham, Thu-Huyen, et al.
Publicado: (2021) -
Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman
por: Singh, Neetu, et al.
Publicado: (2012) -
Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells
por: Jin, Yujin, et al.
Publicado: (2021)